Intrauterine Contraceptive Devices Market Regional Analysis

Skyquest Technology's expert advisors have carried out comprehensive global market analysis on the intrauterine contraceptive devices market, covering regional industry trends and market insights. Our team of analysts have conducted in-depth primary and secondary research to provide regional industry analysis and forecast of intrauterine contraceptive devices market across North America, South America, Europe, Asia, the Middle East, and Africa.

Intrauterine Contraceptive Devices Market Regional Insights

What makes North America the top market for Intrauterine Contraceptive Devices in 2024?

North America dominates the worldwide intrauterine contraceptive devices (IUD) market based on enormous healthcare spends, universal insurance coverages, and continuous government promotion of family planning modes. Geographical focus on solutions to long-acting reversible contraception (LARC) and increased product technology advances for IUD have also benefited the growth process. Access by the leading participants and highly sophisticated existing healthcare systems are another benefit of the region. On top of that, a rise in awareness campaigns and educational programs has increased the popularity and use of IUDs among women, and North America emerged as a global market leader for the second time.

The United States Intrauterine Contraceptive Devices Market

The United States intrauterine devices market reached a revenue of USD 1,560.7 million in 2023 and is anticipated to grow to USD 2,183.4 million by 2030 at a CAGR of 4.9% from 2024-2030. The growth is driven by the widespread usage of hormonal IUDs, which accounted for the leading revenue-generating product segment in 2023. The United States held 25.0% of the world intrauterine devices market in 2023, its gigantic contribution to the world.

Canada Intrauterine Contraceptive Devices Market

Canada will be the fastest-growing country in the North American intrauterine devices market between 2024-2030. Market growth in Canada is driven by increasing awareness about IUDs, favorable government policies, and universal healthcare coverage of IUDs. Between 2023, Canada had USD 88.3 million government funding for bilateral family planning, which reflects the country's focus on reproductive health programs.

How are Government Policies in the Asia-Pacific Driving the Growth of the Intrauterine Contraceptive Devices Market?

Asia Pacific will be the growth-driven intrauterine contraceptive devices market region, led by a fast-growing population, rising demand for effective contraception, and changing healthcare infrastructure. Government initiatives on family planning and women's health, rising awareness and acceptance of new contraceptive technologies, are fueling the market growth. Women empowerment, urbanization, and lifestyle changes in the region also drive the rising use of IUDs.​

Japan Intrauterine Contraceptive Devices Market

Japan's IUD market is recording growth due to advances in technology coupled with increased need for long-acting reversible contraceptives. Japan's population aging as well as its declining birth rate has driven government interest in reproductive health and increased the demand for effective means of contraception such as IUDs. Moreover, partnership among healthcare professionals as well as governments tries to increase access and enhance information on the utilization of IUDs among women.

South Korea Intrauterine Contraceptive Devices Market

South Korea is experiencing growth in the use of IUDs fueled by government-sponsored family planning programs and public awareness of contraceptive devices. Focus on the reproductive health and rights of women in South Korea has also spurred the inclusion of IUDs in South Korea's national health programs. Education interventions and activities supplementing healthcare providers are expanding the acceptability and accessibility of IUDs among South Korean women.

How is Europe Maintaining Its Position in Intrauterine Contraceptive Devices Market?

Europe holds a significant share of the world's intrauterine contraceptive devices market due to higher usage and demand for IUDs, well-developed health infrastructures, and efficient government policies concerning family planning and women's health. Proper emphasis by the region on long-acting reversible contraception, higher awareness about the advantages of IUDs, and pregnancy postponement trend drive the market growth.​

Germany Intrauterine Contraceptive Devices Market

Germany is forecasted to dominate the European intrauterine contraceptive devices market over 2025-2033. Its market growth is being fueled by government efforts, increasing technological progress, and a high abortion rate in the nation, reflecting the necessity of effective contraception strategies. Such technologies as the fertility-sparing intrauterine device, Womed Leaf, with a CE mark in September 2021, are fueling the German IUD market growth.

UK Intrauterine Contraceptive Devices Market

The United Kingdom is expected to have the second-largest market share in the European intrauterine contraceptive devices market. The growth of the country's market is driven by new medical device launches, government initiatives for family planning, and a high rate of IUD usage. The UK emphasis on access to women's reproductive health and services also encourages the use of IUDs. ​

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.6 billion in 2024 to USD 6.6 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

​ The market for intrauterine contraceptive devices (IUD) is highly competitive with established vendors and new-generation companies. Bayer AG possesses the largest market share of approximately 35% because of its differentiated hormonal IUD portfolio, i.e., Mirena, Skyla, and Kyleena, which cater to different patient segments. Merck & Co. possesses the second with approximately 25% market share because of its strong business in hormonal and copper IUD markets, especially in emerging markets. Firms are emphasizing product innovation, i.e., concentrating on the development of small, flexible IUDs for nulliparous women and growing in emerging markets in strategic alliances and public education campaigns. 'Teva Pharmaceutical Industries Ltd. (Jerusalem)', 'Bayer (Germany)', 'EUROGINE (Spain)', 'CooperSurgical Inc. (US)', 'Pfizer Inc. (US)', 'HLL Lifecare Limited (Thiruvananthapuram)', 'OCON Medical Ltd. (Israel)', 'Prosan International BV (Netherlands)', 'Melbea Innovations (Hungary)', 'Allergan, Merck & Co., Inc. (US)', 'DKT International (US)', 'Medisafe Distribution Inc. (Canada)', 'Medicines360 (US)', 'Pregna International Limited (India)', 'Egemen International (Turkey)'

Increasing uptake of long-acting reversible forms of contraception, including intrauterine contraceptive devices (IUDs), is one of the key market drivers. Women are increasingly opting for methods that are effective, low maintenance, and long-acting in preventing pregnancy. IUDs are over 99% effective and have a duration of 3–10 years, depending on the type, and hence provide a convenient option to short-term or daily contraceptives. Secondly, healthcare professionals actively prescribe LARC methods as a first-line contraceptive method and hence propel the use of IUDs. Awareness campaigns regarding the convenience and reliability of LARCs are leading to greater acceptability among various demographic and geographical segments.

Increasing Demand for Non-Hormonal Contraceptives: The demand for non-hormonal intrauterine contraceptive devices is increasing rapidly as more women opt for hormone-free options. Devices such as the Copper IUD are becoming popular due to their long-term nature but non-interference with hormonal balances. This trend is especially strong in those markets with consumers who are health-conscious and choose non-invasive, hormone-free products to escape side effects of hormonal birth control. The market is reacting to the need for more comfort and design in non-hormonal IUDs to meet this increasing demand, and they are now a competitive product on global markets.

What makes North America the top market for Intrauterine Contraceptive Devices in 2024?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Intrauterine Contraceptive Devices Market
Intrauterine Contraceptive Devices Market

Report ID: SQMIG35A3009

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE